Patients with liver cancer expected to undergo radiofrequency ablation or transvascular embolization. Relevant tumor markers (AFP and methylation analysis) were performed. The two data are then counted and compared.
The subjects of this study were patients who were diagnosed with liver cancer by physicians based on AASLD clinical criteria or pathological biopsy. Patients are those who received radiofrequency ablation or transvascular embolization in National Taiwan University Hospital. Which excludes weakness and inability to cooperate Patients with blood test, under the condition of fully informed consent, complete blood test related tumor indicators (AFP and methylation analysis). The two data are then counted Compare.
Study Type
OBSERVATIONAL
Enrollment
90
methylation analysis
National Taiwan University Hospital
Taipei, Taiwan
Evaluate efficacy (methylation profiling results)
Correlation of methylation profiling results with AFP and tumor treatment response.
Time frame: 3 month after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.